Skip to content
Recall Observatory FDA recall evidence

Drug product

Naproxen Sodum Tablets USP 220 mg, (Caplet), Manufactured by: Granules India Limited, Sy.No. 160/A, 161/E, 162, &174/A, Gagillapur Village, Dundigal-Gandimalsamma Monday, Medchai-Maikhajgir District - 500043, Telangana, INDIA. NDC 62207-762-36

D-0777-2021

August 11, 2021

Class II

Product summary

Firm
Granules USA, Inc.
Event
Event 88475
Status
Terminated
Classification
Class II
Quantity
11,450,000 tablets
Official record key
drug-enforcement:D-0777-2021

Official wording

Reason: CGMP Deviations

Code information: 7620060a

Distribution pattern: NY

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations